Biogen Inc. 8-K Filing: Key Developments Revealed on May 1, 2025

Based on the provided section of the financial report, here are the key insights and information extracted:

1. Entity Identification:

• Company Name: Biogen Inc.
• CIK Number: 0000875045
• SEC Central Index Key (CIK): Identifies the company in SEC filings.

2. Filing Type:

• Form Type: 8-K
• Filing Date: May 1, 2025
• The 8-K form is used to report major events that shareholders should know about.

3. Company Information:

• Incorporation State: Delaware (DE)
• IRS Employer Identification Number: 33-0112644
• Address: 225 Binney Street, Cambridge, MA 02142
• Phone Number: 617-679-2000

4. Securities Information:

• Type of Security: Common Stock
• Par Value: $0.0005
• Ticker Symbol: BIIB
• Exchange: NASDAQ

5. Reporting Period:

• Start Date: May 1, 2025
• End Date: May 1, 2025
• The report pertains to a specific event or condition occurring on the same date.

Insights:

• This filing indicates that Biogen Inc. has reported a significant event or development to the SEC on May 1, 2025, as per the requirements of the 8-K form.
• The inclusion of the address and contact information provides stakeholders with the necessary details to reach the company for further inquiries.
• The par value of the common stock suggests a low nominal value, which is common for many publicly traded companies.

This information can be crucial for investors, analysts, and stakeholders monitoring Biogen Inc.'s activities and financial health.